170 related articles for article (PubMed ID: 20082583)
1. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
Elleri D; Acerini CL; Allen JM; Hayes J; Pesterfield C; Wilinska ME; Dunger DB; Hovorka R
Diabetes Technol Ther; 2010 Jan; 12(1):35-9. PubMed ID: 20082583
[TBL] [Abstract][Full Text] [Related]
2. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
[TBL] [Abstract][Full Text] [Related]
4. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.
Hovorka R; Elleri D; Thabit H; Allen JM; Leelarathna L; El-Khairi R; Kumareswaran K; Caldwell K; Calhoun P; Kollman C; Murphy HR; Acerini CL; Wilinska ME; Nodale M; Dunger DB
Diabetes Care; 2014; 37(5):1204-11. PubMed ID: 24757227
[TBL] [Abstract][Full Text] [Related]
5. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
[TBL] [Abstract][Full Text] [Related]
6. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents.
Bisio A; Brown SA; McFadden R; Pajewski M; Yu PL; DeBoer M; Schoelwer MJ; Bonner HG; Wakeman CA; Cherñavvsky DR; Gonder-Frederick L
Pediatr Diabetes; 2021 May; 22(3):495-502. PubMed ID: 33289242
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.
Elleri D; Allen JM; Biagioni M; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
Pediatr Diabetes; 2012 Sep; 13(6):449-53. PubMed ID: 22817340
[TBL] [Abstract][Full Text] [Related]
8. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.
Thabit H; Lubina-Solomon A; Stadler M; Leelarathna L; Walkinshaw E; Pernet A; Allen JM; Iqbal A; Choudhary P; Kumareswaran K; Nodale M; Nisbet C; Wilinska ME; Barnard KD; Dunger DB; Heller SR; Amiel SA; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2014 Sep; 2(9):701-9. PubMed ID: 24943065
[TBL] [Abstract][Full Text] [Related]
9. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
10. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
11. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
[TBL] [Abstract][Full Text] [Related]
12. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
[TBL] [Abstract][Full Text] [Related]
14. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
[TBL] [Abstract][Full Text] [Related]
15. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
[TBL] [Abstract][Full Text] [Related]
16. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
[TBL] [Abstract][Full Text] [Related]
17. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
19. An Evaluation of Glucagon Injection Anxiety and Its Association with the Fear of Hypoglycemia among the Parents of Children with Type 1 Diabetes.
Muradoğlu S; Yeşiltepe Mutlu G; Gökçe T; Can E; Hatun Ş
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):285-292. PubMed ID: 33491925
[TBL] [Abstract][Full Text] [Related]
20. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
